Login |Links | Newsletter | Contact
 News archive
 Newsletter Archive
 EU News
 Sign up for ScanBaltNews
 Summer School in Lapino
 ESF calls for more and better medical imaging rese
 Scandinavian universities join forces to commercialise nanotech
 The Danish Ministry of Science, Technology and Development supports innovation in ScanBalt BioRegion
 Nordplus programmes open to the Baltic States
 New ScanBalt member: the Group for Bioethics in Life Sciences of the Jagiellonian University
 ScanBalt Forum 2008- the first announcement
 Grants for participation at "The first brain aquaporin meeting" in Oslo
 Postgraduate course of the ScanBalt Agrobiotechnology network concluded
 Prof. Glosnicka heads a succesful startup company in the growing biotech industry
 Potocnik calls on Member States to work together on cancer research
 FP7 call: Marie Curie programme
 Commission adopts new health strategy
 FP7 call for proposals: Capacities programme
 FP7 call for proposals: International Cooperation programme
 ScanBalt BioRegion to Collaborate on Cancer
 37 scientists coming back to Lithuania
 Rise of the Nordic warriors
 Biological physics creates diagnostics of the future
 EU Commission signs with ScanBalt to support Small and Medium sized Companies
 Danish model to encourage brain gain
INVESTIGATORS AT INSTITUTE OF BIOTECHNOLOGY PUBLISH NEW DATA ON DNA RESEARCH

A report, "Generation of DNA cleavage specificities of type II restriction endonucleases by reassortment of target recognition domains," is newly published data in Proceedings of the National Academy of Sciences of the United States of America. According to recent research from Vilnius, Lithuania, "Type II restriction endonucleases (REases) cleave double-stranded DNA at specific sites within or close to their recognition sequences. Shortly after their discovery in 1970, REases have become one of the primary tools in molecular biology."

"However, the list of available specificities of type II REases is relatively short despite the extensive search for them in natural sources and multiple attempts to artificially change their specificity. In this study, we examined the possibility of generating cleavage specificities of REases by swapping putative target recognition domains (TRDs) between the type IIB enzymes AloI, PpiI, and TstI. Our results demonstrate that individual TRDs recognize distinct parts of the bipartite DNA targets of these enzymes and are interchangeable. Based on these properties, we engineered a functional type IIB REase having previously undescribed DNA specificity," wrote S. Jurenaite-Urbanaviciene and colleagues, Institute of Biotechnology.

Read more on the report here.

Institute of Biotechnology, Vilnius, Lithuania




design: triip